Government regulates virtually all healthcare services and products. Public sector programs such as Medicare and Medicaid pay for more than half of all healthcare services and products in the U.S. As a result, health policy affects healthcare markets, the financial performance of healthcare companies, and the value of healthcare investments. Our experts partner with clients to anticipate policy changes, to grasp the associated financial opportunities and risks, and to strategize accordingly.
We translate health policy developments on the federal and state levels into timely, concise, actionable insights for financial stakeholders. We support financial sponsors in diligence efforts to assess investments across all healthcare industry subsectors. We are uniquely expert in a multitude of industry concerns, such as health insurance market reforms, healthcare facility and product payment systems, and the economics of medical technologies.
All Avalere insights are supported by rigorous data-driven analytics. We have proprietary analytical models and access to key databases. We build custom models as needed.
For additional information, please email email@example.com.
On-going dialogue about risks and opportunities across healthcare sectors: Regularly written briefs, newsletters, and summaries; Conference calls; In-person meetings.
Due diligence services on potential investments: Initial screening and risk/issue identification, Management meeting preparation and key questions briefing, Detailed due diligence analysis and scenario modeling, Proprietary data analyses.
Strategic help to portfolio companies: Scenario analyses, strategy and implementation advice around legislative, reimbursement and regulatory issues.